DENDRITIC CELL VACCINE IMMUNOTHERAPY IMPROVES SURVIVAL FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

被引：0
|
作者：
Hu, Jethro [1 ]
Wheeler, Christopher J.
Phuphanich, Surasak [1 ]
Rudnick, Jeremy [1 ]
Nuno, Miriam
Serrano, Natalia
Dantis, Jocelynn
Richardson, Jaime
Mazer, Mia
Wang, Hong Qiang
Chu, Ray
Black, Keith L.
Yu, John
机构：
[1] Cedars Sinai Med Ctr, Johnnie Cochran Brain Tumor Ctr, Los Angeles, CA USA
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [21] Everolimus shortens survival of newly diagnosed glioblastoma patients
    Wong, Eric T.
    Swanson, Kenneth D.
    JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (01) : 179 - 180
  • [22] PD-L1 EXPRESSION PREDICTS SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING VACCINE IMMUNOTHERAPY BUT NOT STANDARD THERAPY ALONE
    DiDomenico, Joseph
    Veliceasa, Dorina
    Choy, Winward
    Oyon, Daniel
    Lamano, Jonathan
    Lamano, Jason
    Ampie, Leonel
    Parsa, Andrew
    Bloch, Orin
    NEURO-ONCOLOGY, 2017, 19 : 115 - 115
  • [23] INCREASING TTFIELDS DOSE TO THE TUMOR BED IMPROVES OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS
    Ballo, M.
    Bomzon, Z.
    Urman, N.
    Lavy-Shahaf, G.
    Toms, S. A.
    NEURO-ONCOLOGY, 2018, 20 : 257 - 257
  • [24] Optimizing dendritic cell production and characterization of immune phenotype in patients with newly diagnosed or recurrent glioblastoma
    New, Kent
    Gustafson, Michael
    Bulur, Peggy
    Steinmetz, Susan
    Sprau, Debra
    O'Neill, Brian
    Dietz, Allen
    NEURO-ONCOLOGY, 2007, 9 (04) : 508 - 508
  • [25] TUMOR MARKERS ASSOCIATED WITH INCREASED SURVIVAL IN A PHASE II TRIAL OF DENDRITIC CELL/TUMOR-INITIATING-CELL VACCINE AV-GBM-1 IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Bota, Daniela
    Piccioni, David
    Duma, Christopher
    LaRocca, Renato
    Kesari, Santosh
    Carrillo, Jose
    Hsu, Frank
    Kong, Xiao-Tang
    Abedi, Mehrdad
    Aiken, Robert
    Taylor, Thomas
    Hsieh, Candace
    Nistor, Gabriel
    Dillman, Robert
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A357 - A357
  • [26] A score to predict survival of elderly patients newly diagnosed for Glioblastoma
    Straube, C.
    Kessel, K. A.
    Antoni, S.
    Gempt, J.
    Meyer, B.
    Schlegel, J.
    Schmidt-Graf, F.
    Combs, S. E.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S191 - S192
  • [27] SOCIOECONOMIC STATUS PREDICTS SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Leeper, H. E.
    Johnson, D. R.
    NEURO-ONCOLOGY, 2014, 16
  • [28] Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed Glioblastoma
    Derr, Rachel L.
    Ye, Xiaobu
    Islas, Melissa U.
    Desideri, Serena
    Saudek, Christopher D.
    Grossman, Stuart A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1082 - 1086
  • [29] Dendritic cell immunotherapy for glioblastoma
    Polyzoidis, Stavros
    Ashkan, Keyoumars
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (07) : 761 - 763
  • [30] PERIPHERAL BLOOD LYMPHOCYTE IMMUNE CORRELATES IN GLIOBLASTOMA PATIENTS UNDERGOING DENDRITIC CELL VACCINE IMMUNOTHERAPY
    Fong, B. M.
    Lisiero, D.
    Odesa, S.
    Prins, R.
    Liau, L. M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (01) : 200 - 200
12345